# Characterizing SAPHO With 68Ga-FAPI PET/CT

> **NCT04596462** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 70 (estimated)

## Conditions studied

- SAPHO Syndrome

## Interventions

- **DRUG:** 68Ga-FAPI

## Key facts

- **NCT ID:** NCT04596462
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-08
- **Primary completion:** 2021-06
- **Final completion:** 2021-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04596462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04596462, "Characterizing SAPHO With 68Ga-FAPI PET/CT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04596462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*